Cognition Therapeutics Inc. (NASDAQ: CGTX) Stock Information | RedChip

Cognition Therapeutics Inc. (NASDAQ: CGTX)


$0.6161
-0.0140 ( -2.21% ) 2.6M

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Market Data


Open


$0.6161

Previous close


$0.6301

Volume


2.6M

Market cap


$25.56M

Day range


$0.5780 - $0.6370

52 week range


$0.3400 - $2.9500

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Feb 09, 2024
4 Insider transactions 1 Feb 09, 2024
8-k 8K-related 50 Jan 04, 2024

Latest News